Global Lung Biopsy Systems Supply, Demand and Key Producers, 2026-2032
The global Lung Biopsy Systems market size is expected to reach $ 11005 million by 2032, rising at a market growth of 13.4% CAGR during the forecast period (2026-2032).
Lung Biopsy Systems refer to a set of diagnostic equipment used to safely obtain lung tissue or cytology specimens when evaluating suspicious pulmonary lesions or diffuse lung diseases, typically under endoscopic visualization and or imaging based navigation guidance. A typical system combines a bronchoscope or percutaneous sampling instrument, navigation and localization software or a robotic platform, sampling consumables, and supporting energy or processing units. The scope of this research includes transbronchial biopsy forceps and other miniature sampling tools used in conventional or interventional bronchoscopy, cryobiopsy workstations and cryoprobes used for transbronchial cryobiopsy, lung navigation systems that integrate modalities such as electromagnetic navigation and fluoroscopic guidance, and robotic assisted bronchoscopy platforms designed to reach peripheral lung nodules and support tool in lesion confirmation. It may also be extended to include core needle biopsy instruments used for sampling soft tissues such as the lung. This research excludes the surgical service of open or thoracoscopic lung biopsy, laboratory pathology testing and staining consumables, and standalone imaging equipment such as CT or ultrasound systems. Core use cases include lesion characterization after lung cancer screening, histologic confirmation of peripheral small nodules or ground glass nodules, sampling for mediastinal and hilar staging, and tissue acquisition for interstitial lung disease. The value of these systems lies in improving reach and sample yield, reducing repeat punctures and complication risks, lowering cross infection risk and turnaround costs through single use bronchoscopes and consumable kits, and enabling repeatable standardized workflows and recurring consumable revenues supported by software and robotic assistance. Key customers include tertiary hospitals in pulmonology and thoracic surgery, cancer centers and interventional radiology departments, and specialty clinics that run pulmonary nodule programs and day case procedures. Commercial delivery is commonly structured as capital equipment plus single use consumables or service contracts, and can also incorporate subscription based software modules for navigation planning and data management.
Under the expansion of pulmonary nodule screening and rising demand for early diagnosis, Lung Biopsy Systems are evolving from single sampling tools into end to end solutions centered on reach and confirmation. Robotic assisted bronchoscopy platforms combine stable steerability and distal control with navigation modalities such as shape sensing or imaging fusion, enabling more reliable access to peripheral airways and small nodules that are difficult to reach with conventional bronchoscopes. They embed sampling and tool in lesion confirmation into one workflow, improving diagnostic yield and shortening the path from imaging detection to histologic confirmation. In parallel, electromagnetic and fluoroscopic navigation systems provide a lower barrier pathway in cost and deployment, enhancing localization and route planning without replacing existing bronchoscopy infrastructure, allowing more hospitals to adopt minimally invasive sampling for peripheral lesions. As clinicians increasingly prioritize procedural consistency and learning curve, manufacturers are pushing standardized software workflows, training programs, and matched consumable sets, shifting the field from expert experience driven practice toward device and data driven practice. A key clinical pain point is that smaller and more peripheral lesions are harder to stabilize due to scope bending and recoil, leading to failed sampling or repeated attempts. Shape sensing style navigation reduces reliance on fluoroscopy by providing real time catheter shape and location feedback and can link with CT based airway reconstruction to maintain route consistency in complex branching airways. For hospital operators, the value extends beyond per case yield to include room throughput, reduced anesthesia and length of stay, and measurable quality metrics that support multi center collaboration and research.
Sample quality and safety remain the core competitive dimensions, and consumable innovation directly determines achievable tissue volume and complication control. Conventional biopsy forceps are mature and broadly applicable in bronchoscopy, supporting rapid sampling for central airway disease and selected peripheral targets. To meet the need for larger tissue pieces in interstitial lung disease and peripheral nodules, transbronchial cryobiopsy leverages cryoadhesion to preserve tissue architecture, creating a high value consumable chain built around cryosurgical workstations and single use or reusable cryoprobes. For the percutaneous route, core needle biopsy instruments can provide standardized cylindrical tissue specimens in soft tissues such as the lung, enabling fast confirmation under imaging guidance, while requiring robust pathway planning and complication management. Single use bronchoscopes and compatible sampling instruments are becoming an important complement, reducing cross infection risk and enabling more stable equipment availability and predictable costs in high throughput units. On the consumables side, manufacturers are improving jaw geometry, opening angle, sheath coating straightness, and rotatable handle structures to increase sampling efficiency and reduce mucosal trauma. Some products use color coding and specification systems to differentiate anatomical applications and working channel compatibility, supporting inventory management and nursing setup. Cryobiopsy emphasizes repeatable freeze timing and probe diameter selection, and protective oversheaths can protect scope channels during extraction and reduce thermal damage risk. For percutaneous biopsy, combinations of automatic or semi automatic firing mechanisms with coaxial needle systems help maintain the pathway while enabling multiple passes, increasing diagnostic information per procedure. With accumulating guidelines and evidence, hospitals are more likely to adopt a stratified approach by lesion type, driving coexistence of multiple techniques rather than one technology fully replacing another.
Commercially, Lung Biopsy Systems typically grow through a hybrid model of capital platforms plus recurring consumables. Navigation systems and robotic platforms drive upfront capital purchases, while high frequency consumables such as biopsy forceps, needles, and cryoprobes sustain recurring revenue and incentivize ecosystem optimization. Future growth is expected from three areas, deeper penetration of AI and software in pre procedure planning, intra procedure correction, and reporting and data management, higher sampling volumes driven by the expanding screened population and rising peripheral small nodule detection, and procurement mix shifts driven by the growing adoption of single use endoscopes and consumable kits. From a policy and compliance perspective, tighter requirements on quality systems and infection control will further encourage the use of single use devices and traceable consumables. In manufacturing geography, the US and Europe retain advantages in robotic systems and navigation algorithm platforms, while China, Japan, and Korea are strengthening supply capability in single use endoscopy and endoscopic consumables. In sales geography, North America and Europe are likely to continue leading high end platform installations due to mature screening and interventional pulmonology pathways, while Asia Pacific is positioned as a key incremental market supported by hospital capacity expansion and domestic substitution. In tendering and reimbursement environments, more institutions are incorporating Lung Biopsy Systems into early detection and treatment pathways, building closed loops from screening imaging to follow up and tissue confirmation. Manufacturers reduce post installation friction through interoperability with bronchoscopy towers, fluoroscopy and ultrasound equipment, and through training and service offerings. On the supply chain side, capabilities in key components such as high precision sensors and single use insertion tubes will shape cost curves and may improve accessibility in lower tier markets as scale increases. Competition may evolve along two parallel routes, a high end integrated route centered on robotics and navigation platforms, and a high throughput route centered on single use endoscopy plus standardized consumable bundles, with both developing in parallel across regions and hospital tiers.
This report studies the global Lung Biopsy Systems demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Lung Biopsy Systems, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lung Biopsy Systems that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Lung Biopsy Systems total market, 2021-2032, (USD Million)
Global Lung Biopsy Systems total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Lung Biopsy Systems total market, key domestic companies, and share, (USD Million)
Global Lung Biopsy Systems revenue by player, revenue and market share 2021-2026, (USD Million)
Global Lung Biopsy Systems total market by Type, CAGR, 2021-2032, (USD Million)
Global Lung Biopsy Systems total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Lung Biopsy Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Intuitive Surgical, Inc., Johnson & Johnson MedTech (Ethicon), Medtronic plc, Olympus Corporation, ERBE Elektromedizin GmbH, Ambu A/S, Boston Scientific Corporation, Cook Medical LLC, KARL STORZ SE & Co. KG, Technowood Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Lung Biopsy Systems market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Lung Biopsy Systems Market, By Region:
1. How big is the global Lung Biopsy Systems market?
2. What is the demand of the global Lung Biopsy Systems market?
3. What is the year over year growth of the global Lung Biopsy Systems market?
4. What is the total value of the global Lung Biopsy Systems market?
5. Who are the Major Players in the global Lung Biopsy Systems market?
6. What are the growth factors driving the market demand?
Lung Biopsy Systems refer to a set of diagnostic equipment used to safely obtain lung tissue or cytology specimens when evaluating suspicious pulmonary lesions or diffuse lung diseases, typically under endoscopic visualization and or imaging based navigation guidance. A typical system combines a bronchoscope or percutaneous sampling instrument, navigation and localization software or a robotic platform, sampling consumables, and supporting energy or processing units. The scope of this research includes transbronchial biopsy forceps and other miniature sampling tools used in conventional or interventional bronchoscopy, cryobiopsy workstations and cryoprobes used for transbronchial cryobiopsy, lung navigation systems that integrate modalities such as electromagnetic navigation and fluoroscopic guidance, and robotic assisted bronchoscopy platforms designed to reach peripheral lung nodules and support tool in lesion confirmation. It may also be extended to include core needle biopsy instruments used for sampling soft tissues such as the lung. This research excludes the surgical service of open or thoracoscopic lung biopsy, laboratory pathology testing and staining consumables, and standalone imaging equipment such as CT or ultrasound systems. Core use cases include lesion characterization after lung cancer screening, histologic confirmation of peripheral small nodules or ground glass nodules, sampling for mediastinal and hilar staging, and tissue acquisition for interstitial lung disease. The value of these systems lies in improving reach and sample yield, reducing repeat punctures and complication risks, lowering cross infection risk and turnaround costs through single use bronchoscopes and consumable kits, and enabling repeatable standardized workflows and recurring consumable revenues supported by software and robotic assistance. Key customers include tertiary hospitals in pulmonology and thoracic surgery, cancer centers and interventional radiology departments, and specialty clinics that run pulmonary nodule programs and day case procedures. Commercial delivery is commonly structured as capital equipment plus single use consumables or service contracts, and can also incorporate subscription based software modules for navigation planning and data management.
Under the expansion of pulmonary nodule screening and rising demand for early diagnosis, Lung Biopsy Systems are evolving from single sampling tools into end to end solutions centered on reach and confirmation. Robotic assisted bronchoscopy platforms combine stable steerability and distal control with navigation modalities such as shape sensing or imaging fusion, enabling more reliable access to peripheral airways and small nodules that are difficult to reach with conventional bronchoscopes. They embed sampling and tool in lesion confirmation into one workflow, improving diagnostic yield and shortening the path from imaging detection to histologic confirmation. In parallel, electromagnetic and fluoroscopic navigation systems provide a lower barrier pathway in cost and deployment, enhancing localization and route planning without replacing existing bronchoscopy infrastructure, allowing more hospitals to adopt minimally invasive sampling for peripheral lesions. As clinicians increasingly prioritize procedural consistency and learning curve, manufacturers are pushing standardized software workflows, training programs, and matched consumable sets, shifting the field from expert experience driven practice toward device and data driven practice. A key clinical pain point is that smaller and more peripheral lesions are harder to stabilize due to scope bending and recoil, leading to failed sampling or repeated attempts. Shape sensing style navigation reduces reliance on fluoroscopy by providing real time catheter shape and location feedback and can link with CT based airway reconstruction to maintain route consistency in complex branching airways. For hospital operators, the value extends beyond per case yield to include room throughput, reduced anesthesia and length of stay, and measurable quality metrics that support multi center collaboration and research.
Sample quality and safety remain the core competitive dimensions, and consumable innovation directly determines achievable tissue volume and complication control. Conventional biopsy forceps are mature and broadly applicable in bronchoscopy, supporting rapid sampling for central airway disease and selected peripheral targets. To meet the need for larger tissue pieces in interstitial lung disease and peripheral nodules, transbronchial cryobiopsy leverages cryoadhesion to preserve tissue architecture, creating a high value consumable chain built around cryosurgical workstations and single use or reusable cryoprobes. For the percutaneous route, core needle biopsy instruments can provide standardized cylindrical tissue specimens in soft tissues such as the lung, enabling fast confirmation under imaging guidance, while requiring robust pathway planning and complication management. Single use bronchoscopes and compatible sampling instruments are becoming an important complement, reducing cross infection risk and enabling more stable equipment availability and predictable costs in high throughput units. On the consumables side, manufacturers are improving jaw geometry, opening angle, sheath coating straightness, and rotatable handle structures to increase sampling efficiency and reduce mucosal trauma. Some products use color coding and specification systems to differentiate anatomical applications and working channel compatibility, supporting inventory management and nursing setup. Cryobiopsy emphasizes repeatable freeze timing and probe diameter selection, and protective oversheaths can protect scope channels during extraction and reduce thermal damage risk. For percutaneous biopsy, combinations of automatic or semi automatic firing mechanisms with coaxial needle systems help maintain the pathway while enabling multiple passes, increasing diagnostic information per procedure. With accumulating guidelines and evidence, hospitals are more likely to adopt a stratified approach by lesion type, driving coexistence of multiple techniques rather than one technology fully replacing another.
Commercially, Lung Biopsy Systems typically grow through a hybrid model of capital platforms plus recurring consumables. Navigation systems and robotic platforms drive upfront capital purchases, while high frequency consumables such as biopsy forceps, needles, and cryoprobes sustain recurring revenue and incentivize ecosystem optimization. Future growth is expected from three areas, deeper penetration of AI and software in pre procedure planning, intra procedure correction, and reporting and data management, higher sampling volumes driven by the expanding screened population and rising peripheral small nodule detection, and procurement mix shifts driven by the growing adoption of single use endoscopes and consumable kits. From a policy and compliance perspective, tighter requirements on quality systems and infection control will further encourage the use of single use devices and traceable consumables. In manufacturing geography, the US and Europe retain advantages in robotic systems and navigation algorithm platforms, while China, Japan, and Korea are strengthening supply capability in single use endoscopy and endoscopic consumables. In sales geography, North America and Europe are likely to continue leading high end platform installations due to mature screening and interventional pulmonology pathways, while Asia Pacific is positioned as a key incremental market supported by hospital capacity expansion and domestic substitution. In tendering and reimbursement environments, more institutions are incorporating Lung Biopsy Systems into early detection and treatment pathways, building closed loops from screening imaging to follow up and tissue confirmation. Manufacturers reduce post installation friction through interoperability with bronchoscopy towers, fluoroscopy and ultrasound equipment, and through training and service offerings. On the supply chain side, capabilities in key components such as high precision sensors and single use insertion tubes will shape cost curves and may improve accessibility in lower tier markets as scale increases. Competition may evolve along two parallel routes, a high end integrated route centered on robotics and navigation platforms, and a high throughput route centered on single use endoscopy plus standardized consumable bundles, with both developing in parallel across regions and hospital tiers.
This report studies the global Lung Biopsy Systems demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Lung Biopsy Systems, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lung Biopsy Systems that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Lung Biopsy Systems total market, 2021-2032, (USD Million)
Global Lung Biopsy Systems total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Lung Biopsy Systems total market, key domestic companies, and share, (USD Million)
Global Lung Biopsy Systems revenue by player, revenue and market share 2021-2026, (USD Million)
Global Lung Biopsy Systems total market by Type, CAGR, 2021-2032, (USD Million)
Global Lung Biopsy Systems total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Lung Biopsy Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Intuitive Surgical, Inc., Johnson & Johnson MedTech (Ethicon), Medtronic plc, Olympus Corporation, ERBE Elektromedizin GmbH, Ambu A/S, Boston Scientific Corporation, Cook Medical LLC, KARL STORZ SE & Co. KG, Technowood Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Lung Biopsy Systems market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Lung Biopsy Systems Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Needle Biopsy
- Thoracoscopic Biopsy
- Transbronchial Biopsy
- Bronchoscopic
- Percutaneous
- No Navigation
- Electromagnetic Navigation
- Robotic Navigation
- Shape Sensing
- Hospitals
- Cancer Research Centers
- Specialty Clinics
- Others
- Intuitive Surgical, Inc.
- Johnson & Johnson MedTech (Ethicon)
- Medtronic plc
- Olympus Corporation
- ERBE Elektromedizin GmbH
- Ambu A/S
- Boston Scientific Corporation
- Cook Medical LLC
- KARL STORZ SE & Co. KG
- Technowood Co., Ltd.
- Sumitomo Bakelite Co., Ltd.
- HOYA Corporation (PENTAX Medical)
- FINEMEDIX CO., LTD.
- Upex-Med Corp.
- Medcare Medical (Medcare Medical Co., Ltd.)
- Argon Medical Devices, Inc.
- Becton, Dickinson and Company (BD)
- Hunan Vathin Medical Instrument Co., Ltd.
- Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
- SonoScape Medical Corp.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Jiangsu Vedkang Medical Science and Technology Co., Ltd.
- Zhuji Peng Tian Medical Instrument Co.,Ltd
1. How big is the global Lung Biopsy Systems market?
2. What is the demand of the global Lung Biopsy Systems market?
3. What is the year over year growth of the global Lung Biopsy Systems market?
4. What is the total value of the global Lung Biopsy Systems market?
5. Who are the Major Players in the global Lung Biopsy Systems market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Lung Biopsy Systems Introduction
1.2 World Lung Biopsy Systems Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Lung Biopsy Systems Total Market by Region (by Headquarter Location)
1.3.1 World Lung Biopsy Systems Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.3 China Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.4 Europe Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.5 Japan Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.6 South Korea Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.7 ASEAN Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.8 India Based Company Lung Biopsy Systems Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Lung Biopsy Systems Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Lung Biopsy Systems Consumption Value (2021-2032)
2.2 World Lung Biopsy Systems Consumption Value by Region
2.2.1 World Lung Biopsy Systems Consumption Value by Region (2021-2026)
2.2.2 World Lung Biopsy Systems Consumption Value Forecast by Region (2027-2032)
2.3 United States Lung Biopsy Systems Consumption Value (2021-2032)
2.4 China Lung Biopsy Systems Consumption Value (2021-2032)
2.5 Europe Lung Biopsy Systems Consumption Value (2021-2032)
2.6 Japan Lung Biopsy Systems Consumption Value (2021-2032)
2.7 South Korea Lung Biopsy Systems Consumption Value (2021-2032)
2.8 ASEAN Lung Biopsy Systems Consumption Value (2021-2032)
2.9 India Lung Biopsy Systems Consumption Value (2021-2032)
3 WORLD LUNG BIOPSY SYSTEMS COMPANIES COMPETITIVE ANALYSIS
3.1 World Lung Biopsy Systems Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Lung Biopsy Systems Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Lung Biopsy Systems in 2025
3.2.3 Global Concentration Ratios (CR8) for Lung Biopsy Systems in 2025
3.3 Lung Biopsy Systems Company Evaluation Quadrant
3.4 Lung Biopsy Systems Market: Overall Company Footprint Analysis
3.4.1 Lung Biopsy Systems Market: Region Footprint
3.4.2 Lung Biopsy Systems Market: Company Product Type Footprint
3.4.3 Lung Biopsy Systems Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Lung Biopsy Systems Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Lung Biopsy Systems Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Lung Biopsy Systems Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Lung Biopsy Systems Consumption Value Comparison
4.2.1 United States VS China: Lung Biopsy Systems Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Lung Biopsy Systems Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Lung Biopsy Systems Companies and Market Share, 2021-2026
4.3.1 United States Based Lung Biopsy Systems Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Lung Biopsy Systems Revenue, (2021-2026)
4.4 China Based Companies Lung Biopsy Systems Revenue and Market Share, 2021-2026
4.4.1 China Based Lung Biopsy Systems Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Lung Biopsy Systems Revenue, (2021-2026)
4.5 Rest of World Based Lung Biopsy Systems Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Lung Biopsy Systems Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Lung Biopsy Systems Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Lung Biopsy Systems Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Needle Biopsy
5.2.2 Thoracoscopic Biopsy
5.2.3 Transbronchial Biopsy
5.3 Market Segment by Type
5.3.1 World Lung Biopsy Systems Market Size by Type (2021-2026)
5.3.2 World Lung Biopsy Systems Market Size by Type (2027-2032)
5.3.3 World Lung Biopsy Systems Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ACCESS ROUTE
6.1 World Lung Biopsy Systems Market Size Overview by Access Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Access Route
6.2.1 Bronchoscopic
6.2.2 Percutaneous
6.3 Market Segment by Access Route
6.3.1 World Lung Biopsy Systems Market Size by Access Route (2021-2026)
6.3.2 World Lung Biopsy Systems Market Size by Access Route (2027-2032)
6.3.3 World Lung Biopsy Systems Market Size Market Share by Access Route (2027-2032)
7 MARKET ANALYSIS BY NAVIGATION MODALITY
7.1 World Lung Biopsy Systems Market Size Overview by Navigation Modality: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Navigation Modality
7.2.1 No Navigation
7.2.2 Electromagnetic Navigation
7.2.3 Robotic Navigation
7.2.4 Shape Sensing
7.3 Market Segment by Navigation Modality
7.3.1 World Lung Biopsy Systems Market Size by Navigation Modality (2021-2026)
7.3.2 World Lung Biopsy Systems Market Size by Navigation Modality (2027-2032)
7.3.3 World Lung Biopsy Systems Market Size Market Share by Navigation Modality (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Lung Biopsy Systems Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Cancer Research Centers
8.2.3 Specialty Clinics
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Lung Biopsy Systems Market Size by Application (2021-2026)
8.3.2 World Lung Biopsy Systems Market Size by Application (2027-2032)
8.3.3 World Lung Biopsy Systems Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Intuitive Surgical, Inc.
9.1.1 Intuitive Surgical, Inc. Details
9.1.2 Intuitive Surgical, Inc. Major Business
9.1.3 Intuitive Surgical, Inc. Lung Biopsy Systems Product and Services
9.1.4 Intuitive Surgical, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Intuitive Surgical, Inc. Recent Developments/Updates
9.1.6 Intuitive Surgical, Inc. Competitive Strengths & Weaknesses
9.2 Johnson & Johnson MedTech (Ethicon)
9.2.1 Johnson & Johnson MedTech (Ethicon) Details
9.2.2 Johnson & Johnson MedTech (Ethicon) Major Business
9.2.3 Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Product and Services
9.2.4 Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Johnson & Johnson MedTech (Ethicon) Recent Developments/Updates
9.2.6 Johnson & Johnson MedTech (Ethicon) Competitive Strengths & Weaknesses
9.3 Medtronic plc
9.3.1 Medtronic plc Details
9.3.2 Medtronic plc Major Business
9.3.3 Medtronic plc Lung Biopsy Systems Product and Services
9.3.4 Medtronic plc Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Medtronic plc Recent Developments/Updates
9.3.6 Medtronic plc Competitive Strengths & Weaknesses
9.4 Olympus Corporation
9.4.1 Olympus Corporation Details
9.4.2 Olympus Corporation Major Business
9.4.3 Olympus Corporation Lung Biopsy Systems Product and Services
9.4.4 Olympus Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Olympus Corporation Recent Developments/Updates
9.4.6 Olympus Corporation Competitive Strengths & Weaknesses
9.5 ERBE Elektromedizin GmbH
9.5.1 ERBE Elektromedizin GmbH Details
9.5.2 ERBE Elektromedizin GmbH Major Business
9.5.3 ERBE Elektromedizin GmbH Lung Biopsy Systems Product and Services
9.5.4 ERBE Elektromedizin GmbH Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 ERBE Elektromedizin GmbH Recent Developments/Updates
9.5.6 ERBE Elektromedizin GmbH Competitive Strengths & Weaknesses
9.6 Ambu A/S
9.6.1 Ambu A/S Details
9.6.2 Ambu A/S Major Business
9.6.3 Ambu A/S Lung Biopsy Systems Product and Services
9.6.4 Ambu A/S Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Ambu A/S Recent Developments/Updates
9.6.6 Ambu A/S Competitive Strengths & Weaknesses
9.7 Boston Scientific Corporation
9.7.1 Boston Scientific Corporation Details
9.7.2 Boston Scientific Corporation Major Business
9.7.3 Boston Scientific Corporation Lung Biopsy Systems Product and Services
9.7.4 Boston Scientific Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Boston Scientific Corporation Recent Developments/Updates
9.7.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
9.8 Cook Medical LLC
9.8.1 Cook Medical LLC Details
9.8.2 Cook Medical LLC Major Business
9.8.3 Cook Medical LLC Lung Biopsy Systems Product and Services
9.8.4 Cook Medical LLC Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Cook Medical LLC Recent Developments/Updates
9.8.6 Cook Medical LLC Competitive Strengths & Weaknesses
9.9 KARL STORZ SE & Co. KG
9.9.1 KARL STORZ SE & Co. KG Details
9.9.2 KARL STORZ SE & Co. KG Major Business
9.9.3 KARL STORZ SE & Co. KG Lung Biopsy Systems Product and Services
9.9.4 KARL STORZ SE & Co. KG Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 KARL STORZ SE & Co. KG Recent Developments/Updates
9.9.6 KARL STORZ SE & Co. KG Competitive Strengths & Weaknesses
9.10 Technowood Co., Ltd.
9.10.1 Technowood Co., Ltd. Details
9.10.2 Technowood Co., Ltd. Major Business
9.10.3 Technowood Co., Ltd. Lung Biopsy Systems Product and Services
9.10.4 Technowood Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Technowood Co., Ltd. Recent Developments/Updates
9.10.6 Technowood Co., Ltd. Competitive Strengths & Weaknesses
9.11 Sumitomo Bakelite Co., Ltd.
9.11.1 Sumitomo Bakelite Co., Ltd. Details
9.11.2 Sumitomo Bakelite Co., Ltd. Major Business
9.11.3 Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Product and Services
9.11.4 Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Sumitomo Bakelite Co., Ltd. Recent Developments/Updates
9.11.6 Sumitomo Bakelite Co., Ltd. Competitive Strengths & Weaknesses
9.12 HOYA Corporation (PENTAX Medical)
9.12.1 HOYA Corporation (PENTAX Medical) Details
9.12.2 HOYA Corporation (PENTAX Medical) Major Business
9.12.3 HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Product and Services
9.12.4 HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 HOYA Corporation (PENTAX Medical) Recent Developments/Updates
9.12.6 HOYA Corporation (PENTAX Medical) Competitive Strengths & Weaknesses
9.13 FINEMEDIX CO., LTD.
9.13.1 FINEMEDIX CO., LTD. Details
9.13.2 FINEMEDIX CO., LTD. Major Business
9.13.3 FINEMEDIX CO., LTD. Lung Biopsy Systems Product and Services
9.13.4 FINEMEDIX CO., LTD. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 FINEMEDIX CO., LTD. Recent Developments/Updates
9.13.6 FINEMEDIX CO., LTD. Competitive Strengths & Weaknesses
9.14 Upex-Med Corp.
9.14.1 Upex-Med Corp. Details
9.14.2 Upex-Med Corp. Major Business
9.14.3 Upex-Med Corp. Lung Biopsy Systems Product and Services
9.14.4 Upex-Med Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Upex-Med Corp. Recent Developments/Updates
9.14.6 Upex-Med Corp. Competitive Strengths & Weaknesses
9.15 Medcare Medical (Medcare Medical Co., Ltd.)
9.15.1 Medcare Medical (Medcare Medical Co., Ltd.) Details
9.15.2 Medcare Medical (Medcare Medical Co., Ltd.) Major Business
9.15.3 Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Product and Services
9.15.4 Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Medcare Medical (Medcare Medical Co., Ltd.) Recent Developments/Updates
9.15.6 Medcare Medical (Medcare Medical Co., Ltd.) Competitive Strengths & Weaknesses
9.16 Argon Medical Devices, Inc.
9.16.1 Argon Medical Devices, Inc. Details
9.16.2 Argon Medical Devices, Inc. Major Business
9.16.3 Argon Medical Devices, Inc. Lung Biopsy Systems Product and Services
9.16.4 Argon Medical Devices, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Argon Medical Devices, Inc. Recent Developments/Updates
9.16.6 Argon Medical Devices, Inc. Competitive Strengths & Weaknesses
9.17 Becton, Dickinson and Company (BD)
9.17.1 Becton, Dickinson and Company (BD) Details
9.17.2 Becton, Dickinson and Company (BD) Major Business
9.17.3 Becton, Dickinson and Company (BD) Lung Biopsy Systems Product and Services
9.17.4 Becton, Dickinson and Company (BD) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Becton, Dickinson and Company (BD) Recent Developments/Updates
9.17.6 Becton, Dickinson and Company (BD) Competitive Strengths & Weaknesses
9.18 Hunan Vathin Medical Instrument Co., Ltd.
9.18.1 Hunan Vathin Medical Instrument Co., Ltd. Details
9.18.2 Hunan Vathin Medical Instrument Co., Ltd. Major Business
9.18.3 Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Product and Services
9.18.4 Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Hunan Vathin Medical Instrument Co., Ltd. Recent Developments/Updates
9.18.6 Hunan Vathin Medical Instrument Co., Ltd. Competitive Strengths & Weaknesses
9.19 Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
9.19.1 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Details
9.19.2 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Major Business
9.19.3 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Product and Services
9.19.4 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Recent Developments/Updates
9.19.6 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Competitive Strengths & Weaknesses
9.20 SonoScape Medical Corp.
9.20.1 SonoScape Medical Corp. Details
9.20.2 SonoScape Medical Corp. Major Business
9.20.3 SonoScape Medical Corp. Lung Biopsy Systems Product and Services
9.20.4 SonoScape Medical Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 SonoScape Medical Corp. Recent Developments/Updates
9.20.6 SonoScape Medical Corp. Competitive Strengths & Weaknesses
9.21 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.21.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Details
9.21.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
9.21.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Product and Services
9.21.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
9.21.6 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitive Strengths & Weaknesses
9.22 Jiangsu Vedkang Medical Science and Technology Co., Ltd.
9.22.1 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Details
9.22.2 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Major Business
9.22.3 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Product and Services
9.22.4 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Recent Developments/Updates
9.22.6 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Competitive Strengths & Weaknesses
9.23 Zhuji Peng Tian Medical Instrument Co.,Ltd
9.23.1 Zhuji Peng Tian Medical Instrument Co.,Ltd Details
9.23.2 Zhuji Peng Tian Medical Instrument Co.,Ltd Major Business
9.23.3 Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Product and Services
9.23.4 Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Zhuji Peng Tian Medical Instrument Co.,Ltd Recent Developments/Updates
9.23.6 Zhuji Peng Tian Medical Instrument Co.,Ltd Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Lung Biopsy Systems Industry Chain
10.2 Lung Biopsy Systems Upstream Analysis
10.3 Lung Biopsy Systems Midstream Analysis
10.4 Lung Biopsy Systems Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Lung Biopsy Systems Introduction
1.2 World Lung Biopsy Systems Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Lung Biopsy Systems Total Market by Region (by Headquarter Location)
1.3.1 World Lung Biopsy Systems Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.3 China Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.4 Europe Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.5 Japan Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.6 South Korea Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.7 ASEAN Based Company Lung Biopsy Systems Revenue (2021-2032)
1.3.8 India Based Company Lung Biopsy Systems Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Lung Biopsy Systems Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Lung Biopsy Systems Consumption Value (2021-2032)
2.2 World Lung Biopsy Systems Consumption Value by Region
2.2.1 World Lung Biopsy Systems Consumption Value by Region (2021-2026)
2.2.2 World Lung Biopsy Systems Consumption Value Forecast by Region (2027-2032)
2.3 United States Lung Biopsy Systems Consumption Value (2021-2032)
2.4 China Lung Biopsy Systems Consumption Value (2021-2032)
2.5 Europe Lung Biopsy Systems Consumption Value (2021-2032)
2.6 Japan Lung Biopsy Systems Consumption Value (2021-2032)
2.7 South Korea Lung Biopsy Systems Consumption Value (2021-2032)
2.8 ASEAN Lung Biopsy Systems Consumption Value (2021-2032)
2.9 India Lung Biopsy Systems Consumption Value (2021-2032)
3 WORLD LUNG BIOPSY SYSTEMS COMPANIES COMPETITIVE ANALYSIS
3.1 World Lung Biopsy Systems Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Lung Biopsy Systems Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Lung Biopsy Systems in 2025
3.2.3 Global Concentration Ratios (CR8) for Lung Biopsy Systems in 2025
3.3 Lung Biopsy Systems Company Evaluation Quadrant
3.4 Lung Biopsy Systems Market: Overall Company Footprint Analysis
3.4.1 Lung Biopsy Systems Market: Region Footprint
3.4.2 Lung Biopsy Systems Market: Company Product Type Footprint
3.4.3 Lung Biopsy Systems Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Lung Biopsy Systems Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Lung Biopsy Systems Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Lung Biopsy Systems Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Lung Biopsy Systems Consumption Value Comparison
4.2.1 United States VS China: Lung Biopsy Systems Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Lung Biopsy Systems Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Lung Biopsy Systems Companies and Market Share, 2021-2026
4.3.1 United States Based Lung Biopsy Systems Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Lung Biopsy Systems Revenue, (2021-2026)
4.4 China Based Companies Lung Biopsy Systems Revenue and Market Share, 2021-2026
4.4.1 China Based Lung Biopsy Systems Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Lung Biopsy Systems Revenue, (2021-2026)
4.5 Rest of World Based Lung Biopsy Systems Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Lung Biopsy Systems Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Lung Biopsy Systems Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Lung Biopsy Systems Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Needle Biopsy
5.2.2 Thoracoscopic Biopsy
5.2.3 Transbronchial Biopsy
5.3 Market Segment by Type
5.3.1 World Lung Biopsy Systems Market Size by Type (2021-2026)
5.3.2 World Lung Biopsy Systems Market Size by Type (2027-2032)
5.3.3 World Lung Biopsy Systems Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ACCESS ROUTE
6.1 World Lung Biopsy Systems Market Size Overview by Access Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Access Route
6.2.1 Bronchoscopic
6.2.2 Percutaneous
6.3 Market Segment by Access Route
6.3.1 World Lung Biopsy Systems Market Size by Access Route (2021-2026)
6.3.2 World Lung Biopsy Systems Market Size by Access Route (2027-2032)
6.3.3 World Lung Biopsy Systems Market Size Market Share by Access Route (2027-2032)
7 MARKET ANALYSIS BY NAVIGATION MODALITY
7.1 World Lung Biopsy Systems Market Size Overview by Navigation Modality: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Navigation Modality
7.2.1 No Navigation
7.2.2 Electromagnetic Navigation
7.2.3 Robotic Navigation
7.2.4 Shape Sensing
7.3 Market Segment by Navigation Modality
7.3.1 World Lung Biopsy Systems Market Size by Navigation Modality (2021-2026)
7.3.2 World Lung Biopsy Systems Market Size by Navigation Modality (2027-2032)
7.3.3 World Lung Biopsy Systems Market Size Market Share by Navigation Modality (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Lung Biopsy Systems Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Cancer Research Centers
8.2.3 Specialty Clinics
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Lung Biopsy Systems Market Size by Application (2021-2026)
8.3.2 World Lung Biopsy Systems Market Size by Application (2027-2032)
8.3.3 World Lung Biopsy Systems Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Intuitive Surgical, Inc.
9.1.1 Intuitive Surgical, Inc. Details
9.1.2 Intuitive Surgical, Inc. Major Business
9.1.3 Intuitive Surgical, Inc. Lung Biopsy Systems Product and Services
9.1.4 Intuitive Surgical, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Intuitive Surgical, Inc. Recent Developments/Updates
9.1.6 Intuitive Surgical, Inc. Competitive Strengths & Weaknesses
9.2 Johnson & Johnson MedTech (Ethicon)
9.2.1 Johnson & Johnson MedTech (Ethicon) Details
9.2.2 Johnson & Johnson MedTech (Ethicon) Major Business
9.2.3 Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Product and Services
9.2.4 Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Johnson & Johnson MedTech (Ethicon) Recent Developments/Updates
9.2.6 Johnson & Johnson MedTech (Ethicon) Competitive Strengths & Weaknesses
9.3 Medtronic plc
9.3.1 Medtronic plc Details
9.3.2 Medtronic plc Major Business
9.3.3 Medtronic plc Lung Biopsy Systems Product and Services
9.3.4 Medtronic plc Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Medtronic plc Recent Developments/Updates
9.3.6 Medtronic plc Competitive Strengths & Weaknesses
9.4 Olympus Corporation
9.4.1 Olympus Corporation Details
9.4.2 Olympus Corporation Major Business
9.4.3 Olympus Corporation Lung Biopsy Systems Product and Services
9.4.4 Olympus Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Olympus Corporation Recent Developments/Updates
9.4.6 Olympus Corporation Competitive Strengths & Weaknesses
9.5 ERBE Elektromedizin GmbH
9.5.1 ERBE Elektromedizin GmbH Details
9.5.2 ERBE Elektromedizin GmbH Major Business
9.5.3 ERBE Elektromedizin GmbH Lung Biopsy Systems Product and Services
9.5.4 ERBE Elektromedizin GmbH Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 ERBE Elektromedizin GmbH Recent Developments/Updates
9.5.6 ERBE Elektromedizin GmbH Competitive Strengths & Weaknesses
9.6 Ambu A/S
9.6.1 Ambu A/S Details
9.6.2 Ambu A/S Major Business
9.6.3 Ambu A/S Lung Biopsy Systems Product and Services
9.6.4 Ambu A/S Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Ambu A/S Recent Developments/Updates
9.6.6 Ambu A/S Competitive Strengths & Weaknesses
9.7 Boston Scientific Corporation
9.7.1 Boston Scientific Corporation Details
9.7.2 Boston Scientific Corporation Major Business
9.7.3 Boston Scientific Corporation Lung Biopsy Systems Product and Services
9.7.4 Boston Scientific Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Boston Scientific Corporation Recent Developments/Updates
9.7.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
9.8 Cook Medical LLC
9.8.1 Cook Medical LLC Details
9.8.2 Cook Medical LLC Major Business
9.8.3 Cook Medical LLC Lung Biopsy Systems Product and Services
9.8.4 Cook Medical LLC Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Cook Medical LLC Recent Developments/Updates
9.8.6 Cook Medical LLC Competitive Strengths & Weaknesses
9.9 KARL STORZ SE & Co. KG
9.9.1 KARL STORZ SE & Co. KG Details
9.9.2 KARL STORZ SE & Co. KG Major Business
9.9.3 KARL STORZ SE & Co. KG Lung Biopsy Systems Product and Services
9.9.4 KARL STORZ SE & Co. KG Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 KARL STORZ SE & Co. KG Recent Developments/Updates
9.9.6 KARL STORZ SE & Co. KG Competitive Strengths & Weaknesses
9.10 Technowood Co., Ltd.
9.10.1 Technowood Co., Ltd. Details
9.10.2 Technowood Co., Ltd. Major Business
9.10.3 Technowood Co., Ltd. Lung Biopsy Systems Product and Services
9.10.4 Technowood Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Technowood Co., Ltd. Recent Developments/Updates
9.10.6 Technowood Co., Ltd. Competitive Strengths & Weaknesses
9.11 Sumitomo Bakelite Co., Ltd.
9.11.1 Sumitomo Bakelite Co., Ltd. Details
9.11.2 Sumitomo Bakelite Co., Ltd. Major Business
9.11.3 Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Product and Services
9.11.4 Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Sumitomo Bakelite Co., Ltd. Recent Developments/Updates
9.11.6 Sumitomo Bakelite Co., Ltd. Competitive Strengths & Weaknesses
9.12 HOYA Corporation (PENTAX Medical)
9.12.1 HOYA Corporation (PENTAX Medical) Details
9.12.2 HOYA Corporation (PENTAX Medical) Major Business
9.12.3 HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Product and Services
9.12.4 HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 HOYA Corporation (PENTAX Medical) Recent Developments/Updates
9.12.6 HOYA Corporation (PENTAX Medical) Competitive Strengths & Weaknesses
9.13 FINEMEDIX CO., LTD.
9.13.1 FINEMEDIX CO., LTD. Details
9.13.2 FINEMEDIX CO., LTD. Major Business
9.13.3 FINEMEDIX CO., LTD. Lung Biopsy Systems Product and Services
9.13.4 FINEMEDIX CO., LTD. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 FINEMEDIX CO., LTD. Recent Developments/Updates
9.13.6 FINEMEDIX CO., LTD. Competitive Strengths & Weaknesses
9.14 Upex-Med Corp.
9.14.1 Upex-Med Corp. Details
9.14.2 Upex-Med Corp. Major Business
9.14.3 Upex-Med Corp. Lung Biopsy Systems Product and Services
9.14.4 Upex-Med Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Upex-Med Corp. Recent Developments/Updates
9.14.6 Upex-Med Corp. Competitive Strengths & Weaknesses
9.15 Medcare Medical (Medcare Medical Co., Ltd.)
9.15.1 Medcare Medical (Medcare Medical Co., Ltd.) Details
9.15.2 Medcare Medical (Medcare Medical Co., Ltd.) Major Business
9.15.3 Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Product and Services
9.15.4 Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Medcare Medical (Medcare Medical Co., Ltd.) Recent Developments/Updates
9.15.6 Medcare Medical (Medcare Medical Co., Ltd.) Competitive Strengths & Weaknesses
9.16 Argon Medical Devices, Inc.
9.16.1 Argon Medical Devices, Inc. Details
9.16.2 Argon Medical Devices, Inc. Major Business
9.16.3 Argon Medical Devices, Inc. Lung Biopsy Systems Product and Services
9.16.4 Argon Medical Devices, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Argon Medical Devices, Inc. Recent Developments/Updates
9.16.6 Argon Medical Devices, Inc. Competitive Strengths & Weaknesses
9.17 Becton, Dickinson and Company (BD)
9.17.1 Becton, Dickinson and Company (BD) Details
9.17.2 Becton, Dickinson and Company (BD) Major Business
9.17.3 Becton, Dickinson and Company (BD) Lung Biopsy Systems Product and Services
9.17.4 Becton, Dickinson and Company (BD) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Becton, Dickinson and Company (BD) Recent Developments/Updates
9.17.6 Becton, Dickinson and Company (BD) Competitive Strengths & Weaknesses
9.18 Hunan Vathin Medical Instrument Co., Ltd.
9.18.1 Hunan Vathin Medical Instrument Co., Ltd. Details
9.18.2 Hunan Vathin Medical Instrument Co., Ltd. Major Business
9.18.3 Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Product and Services
9.18.4 Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Hunan Vathin Medical Instrument Co., Ltd. Recent Developments/Updates
9.18.6 Hunan Vathin Medical Instrument Co., Ltd. Competitive Strengths & Weaknesses
9.19 Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
9.19.1 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Details
9.19.2 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Major Business
9.19.3 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Product and Services
9.19.4 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Recent Developments/Updates
9.19.6 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Competitive Strengths & Weaknesses
9.20 SonoScape Medical Corp.
9.20.1 SonoScape Medical Corp. Details
9.20.2 SonoScape Medical Corp. Major Business
9.20.3 SonoScape Medical Corp. Lung Biopsy Systems Product and Services
9.20.4 SonoScape Medical Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 SonoScape Medical Corp. Recent Developments/Updates
9.20.6 SonoScape Medical Corp. Competitive Strengths & Weaknesses
9.21 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.21.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Details
9.21.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
9.21.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Product and Services
9.21.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
9.21.6 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitive Strengths & Weaknesses
9.22 Jiangsu Vedkang Medical Science and Technology Co., Ltd.
9.22.1 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Details
9.22.2 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Major Business
9.22.3 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Product and Services
9.22.4 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Recent Developments/Updates
9.22.6 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Competitive Strengths & Weaknesses
9.23 Zhuji Peng Tian Medical Instrument Co.,Ltd
9.23.1 Zhuji Peng Tian Medical Instrument Co.,Ltd Details
9.23.2 Zhuji Peng Tian Medical Instrument Co.,Ltd Major Business
9.23.3 Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Product and Services
9.23.4 Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Zhuji Peng Tian Medical Instrument Co.,Ltd Recent Developments/Updates
9.23.6 Zhuji Peng Tian Medical Instrument Co.,Ltd Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Lung Biopsy Systems Industry Chain
10.2 Lung Biopsy Systems Upstream Analysis
10.3 Lung Biopsy Systems Midstream Analysis
10.4 Lung Biopsy Systems Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Lung Biopsy Systems Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Lung Biopsy Systems Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Lung Biopsy Systems Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Lung Biopsy Systems Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Lung Biopsy Systems Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Lung Biopsy Systems Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Lung Biopsy Systems Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Lung Biopsy Systems Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Lung Biopsy Systems Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Lung Biopsy Systems Players in 2025
Table 12. World Lung Biopsy Systems Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Lung Biopsy Systems Company Evaluation Quadrant
Table 14. Head Office of Key Lung Biopsy Systems Players
Table 15. Lung Biopsy Systems Market: Company Product Type Footprint
Table 16. Lung Biopsy Systems Market: Company Product Application Footprint
Table 17. Lung Biopsy Systems Mergers & Acquisitions Activity
Table 18. United States VS China Lung Biopsy Systems Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Lung Biopsy Systems Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Lung Biopsy Systems Companies, Headquarters (States, Country)
Table 21. United States Based Companies Lung Biopsy Systems Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Lung Biopsy Systems Revenue Market Share (2021-2026)
Table 23. China Based Lung Biopsy Systems Companies, Headquarters (Province, Country)
Table 24. China Based Companies Lung Biopsy Systems Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Lung Biopsy Systems Revenue Market Share (2021-2026)
Table 26. Rest of World Based Lung Biopsy Systems Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Lung Biopsy Systems Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Lung Biopsy Systems Revenue Market Share (2021-2026)
Table 29. World Lung Biopsy Systems Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Lung Biopsy Systems Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Lung Biopsy Systems Market Size by Type (2027-2032) & (USD Million)
Table 32. World Lung Biopsy Systems Market Size by Access Route, (USD Million), 2021 & 2025 & 2032
Table 33. World Lung Biopsy Systems Market Size Value by Access Route (2021-2026) & (USD Million)
Table 34. World Lung Biopsy Systems Market Size by Access Route (2027-2032) & (USD Million)
Table 35. World Lung Biopsy Systems Market Size by Navigation Modality, (USD Million), 2021 & 2025 & 2032
Table 36. World Lung Biopsy Systems Market Size Value by Navigation Modality (2021-2026) & (USD Million)
Table 37. World Lung Biopsy Systems Market Size by Navigation Modality (2027-2032) & (USD Million)
Table 38. World Lung Biopsy Systems Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Lung Biopsy Systems Market Size by Application (2021-2026) & (USD Million)
Table 40. World Lung Biopsy Systems Market Size by Application (2027-2032) & (USD Million)
Table 41. Intuitive Surgical, Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Intuitive Surgical, Inc. Major Business
Table 43. Intuitive Surgical, Inc. Lung Biopsy Systems Product and Services
Table 44. Intuitive Surgical, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Intuitive Surgical, Inc. Recent Developments/Updates
Table 46. Intuitive Surgical, Inc. Competitive Strengths & Weaknesses
Table 47. Johnson & Johnson MedTech (Ethicon) Basic Information, Manufacturing Base and Competitors
Table 48. Johnson & Johnson MedTech (Ethicon) Major Business
Table 49. Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Product and Services
Table 50. Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Johnson & Johnson MedTech (Ethicon) Recent Developments/Updates
Table 52. Johnson & Johnson MedTech (Ethicon) Competitive Strengths & Weaknesses
Table 53. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 54. Medtronic plc Major Business
Table 55. Medtronic plc Lung Biopsy Systems Product and Services
Table 56. Medtronic plc Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Medtronic plc Recent Developments/Updates
Table 58. Medtronic plc Competitive Strengths & Weaknesses
Table 59. Olympus Corporation Basic Information, Manufacturing Base and Competitors
Table 60. Olympus Corporation Major Business
Table 61. Olympus Corporation Lung Biopsy Systems Product and Services
Table 62. Olympus Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Olympus Corporation Recent Developments/Updates
Table 64. Olympus Corporation Competitive Strengths & Weaknesses
Table 65. ERBE Elektromedizin GmbH Basic Information, Manufacturing Base and Competitors
Table 66. ERBE Elektromedizin GmbH Major Business
Table 67. ERBE Elektromedizin GmbH Lung Biopsy Systems Product and Services
Table 68. ERBE Elektromedizin GmbH Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. ERBE Elektromedizin GmbH Recent Developments/Updates
Table 70. ERBE Elektromedizin GmbH Competitive Strengths & Weaknesses
Table 71. Ambu A/S Basic Information, Manufacturing Base and Competitors
Table 72. Ambu A/S Major Business
Table 73. Ambu A/S Lung Biopsy Systems Product and Services
Table 74. Ambu A/S Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Ambu A/S Recent Developments/Updates
Table 76. Ambu A/S Competitive Strengths & Weaknesses
Table 77. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 78. Boston Scientific Corporation Major Business
Table 79. Boston Scientific Corporation Lung Biopsy Systems Product and Services
Table 80. Boston Scientific Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Boston Scientific Corporation Recent Developments/Updates
Table 82. Boston Scientific Corporation Competitive Strengths & Weaknesses
Table 83. Cook Medical LLC Basic Information, Manufacturing Base and Competitors
Table 84. Cook Medical LLC Major Business
Table 85. Cook Medical LLC Lung Biopsy Systems Product and Services
Table 86. Cook Medical LLC Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Cook Medical LLC Recent Developments/Updates
Table 88. Cook Medical LLC Competitive Strengths & Weaknesses
Table 89. KARL STORZ SE & Co. KG Basic Information, Manufacturing Base and Competitors
Table 90. KARL STORZ SE & Co. KG Major Business
Table 91. KARL STORZ SE & Co. KG Lung Biopsy Systems Product and Services
Table 92. KARL STORZ SE & Co. KG Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. KARL STORZ SE & Co. KG Recent Developments/Updates
Table 94. KARL STORZ SE & Co. KG Competitive Strengths & Weaknesses
Table 95. Technowood Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. Technowood Co., Ltd. Major Business
Table 97. Technowood Co., Ltd. Lung Biopsy Systems Product and Services
Table 98. Technowood Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Technowood Co., Ltd. Recent Developments/Updates
Table 100. Technowood Co., Ltd. Competitive Strengths & Weaknesses
Table 101. Sumitomo Bakelite Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 102. Sumitomo Bakelite Co., Ltd. Major Business
Table 103. Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Product and Services
Table 104. Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Sumitomo Bakelite Co., Ltd. Recent Developments/Updates
Table 106. Sumitomo Bakelite Co., Ltd. Competitive Strengths & Weaknesses
Table 107. HOYA Corporation (PENTAX Medical) Basic Information, Manufacturing Base and Competitors
Table 108. HOYA Corporation (PENTAX Medical) Major Business
Table 109. HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Product and Services
Table 110. HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. HOYA Corporation (PENTAX Medical) Recent Developments/Updates
Table 112. HOYA Corporation (PENTAX Medical) Competitive Strengths & Weaknesses
Table 113. FINEMEDIX CO., LTD. Basic Information, Manufacturing Base and Competitors
Table 114. FINEMEDIX CO., LTD. Major Business
Table 115. FINEMEDIX CO., LTD. Lung Biopsy Systems Product and Services
Table 116. FINEMEDIX CO., LTD. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. FINEMEDIX CO., LTD. Recent Developments/Updates
Table 118. FINEMEDIX CO., LTD. Competitive Strengths & Weaknesses
Table 119. Upex-Med Corp. Basic Information, Manufacturing Base and Competitors
Table 120. Upex-Med Corp. Major Business
Table 121. Upex-Med Corp. Lung Biopsy Systems Product and Services
Table 122. Upex-Med Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Upex-Med Corp. Recent Developments/Updates
Table 124. Upex-Med Corp. Competitive Strengths & Weaknesses
Table 125. Medcare Medical (Medcare Medical Co., Ltd.) Basic Information, Manufacturing Base and Competitors
Table 126. Medcare Medical (Medcare Medical Co., Ltd.) Major Business
Table 127. Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Product and Services
Table 128. Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Medcare Medical (Medcare Medical Co., Ltd.) Recent Developments/Updates
Table 130. Medcare Medical (Medcare Medical Co., Ltd.) Competitive Strengths & Weaknesses
Table 131. Argon Medical Devices, Inc. Basic Information, Manufacturing Base and Competitors
Table 132. Argon Medical Devices, Inc. Major Business
Table 133. Argon Medical Devices, Inc. Lung Biopsy Systems Product and Services
Table 134. Argon Medical Devices, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Argon Medical Devices, Inc. Recent Developments/Updates
Table 136. Argon Medical Devices, Inc. Competitive Strengths & Weaknesses
Table 137. Becton, Dickinson and Company (BD) Basic Information, Manufacturing Base and Competitors
Table 138. Becton, Dickinson and Company (BD) Major Business
Table 139. Becton, Dickinson and Company (BD) Lung Biopsy Systems Product and Services
Table 140. Becton, Dickinson and Company (BD) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Becton, Dickinson and Company (BD) Recent Developments/Updates
Table 142. Becton, Dickinson and Company (BD) Competitive Strengths & Weaknesses
Table 143. Hunan Vathin Medical Instrument Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 144. Hunan Vathin Medical Instrument Co., Ltd. Major Business
Table 145. Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Product and Services
Table 146. Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Hunan Vathin Medical Instrument Co., Ltd. Recent Developments/Updates
Table 148. Hunan Vathin Medical Instrument Co., Ltd. Competitive Strengths & Weaknesses
Table 149. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 150. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Major Business
Table 151. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Product and Services
Table 152. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Recent Developments/Updates
Table 154. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Competitive Strengths & Weaknesses
Table 155. SonoScape Medical Corp. Basic Information, Manufacturing Base and Competitors
Table 156. SonoScape Medical Corp. Major Business
Table 157. SonoScape Medical Corp. Lung Biopsy Systems Product and Services
Table 158. SonoScape Medical Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. SonoScape Medical Corp. Recent Developments/Updates
Table 160. SonoScape Medical Corp. Competitive Strengths & Weaknesses
Table 161. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 162. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
Table 163. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Product and Services
Table 164. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
Table 166. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitive Strengths & Weaknesses
Table 167. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 168. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Major Business
Table 169. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Product and Services
Table 170. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Recent Developments/Updates
Table 172. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 173. Zhuji Peng Tian Medical Instrument Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 174. Zhuji Peng Tian Medical Instrument Co.,Ltd Major Business
Table 175. Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Product and Services
Table 176. Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Zhuji Peng Tian Medical Instrument Co.,Ltd Recent Developments/Updates
Table 178. Zhuji Peng Tian Medical Instrument Co.,Ltd Competitive Strengths & Weaknesses
Table 179. Global Key Players of Lung Biopsy Systems Upstream (Raw Materials)
Table 180. Global Lung Biopsy Systems Typical Customers
Table 1. World Lung Biopsy Systems Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Lung Biopsy Systems Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Lung Biopsy Systems Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Lung Biopsy Systems Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Lung Biopsy Systems Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Lung Biopsy Systems Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Lung Biopsy Systems Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Lung Biopsy Systems Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Lung Biopsy Systems Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Lung Biopsy Systems Players in 2025
Table 12. World Lung Biopsy Systems Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Lung Biopsy Systems Company Evaluation Quadrant
Table 14. Head Office of Key Lung Biopsy Systems Players
Table 15. Lung Biopsy Systems Market: Company Product Type Footprint
Table 16. Lung Biopsy Systems Market: Company Product Application Footprint
Table 17. Lung Biopsy Systems Mergers & Acquisitions Activity
Table 18. United States VS China Lung Biopsy Systems Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Lung Biopsy Systems Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Lung Biopsy Systems Companies, Headquarters (States, Country)
Table 21. United States Based Companies Lung Biopsy Systems Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Lung Biopsy Systems Revenue Market Share (2021-2026)
Table 23. China Based Lung Biopsy Systems Companies, Headquarters (Province, Country)
Table 24. China Based Companies Lung Biopsy Systems Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Lung Biopsy Systems Revenue Market Share (2021-2026)
Table 26. Rest of World Based Lung Biopsy Systems Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Lung Biopsy Systems Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Lung Biopsy Systems Revenue Market Share (2021-2026)
Table 29. World Lung Biopsy Systems Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Lung Biopsy Systems Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Lung Biopsy Systems Market Size by Type (2027-2032) & (USD Million)
Table 32. World Lung Biopsy Systems Market Size by Access Route, (USD Million), 2021 & 2025 & 2032
Table 33. World Lung Biopsy Systems Market Size Value by Access Route (2021-2026) & (USD Million)
Table 34. World Lung Biopsy Systems Market Size by Access Route (2027-2032) & (USD Million)
Table 35. World Lung Biopsy Systems Market Size by Navigation Modality, (USD Million), 2021 & 2025 & 2032
Table 36. World Lung Biopsy Systems Market Size Value by Navigation Modality (2021-2026) & (USD Million)
Table 37. World Lung Biopsy Systems Market Size by Navigation Modality (2027-2032) & (USD Million)
Table 38. World Lung Biopsy Systems Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Lung Biopsy Systems Market Size by Application (2021-2026) & (USD Million)
Table 40. World Lung Biopsy Systems Market Size by Application (2027-2032) & (USD Million)
Table 41. Intuitive Surgical, Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Intuitive Surgical, Inc. Major Business
Table 43. Intuitive Surgical, Inc. Lung Biopsy Systems Product and Services
Table 44. Intuitive Surgical, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Intuitive Surgical, Inc. Recent Developments/Updates
Table 46. Intuitive Surgical, Inc. Competitive Strengths & Weaknesses
Table 47. Johnson & Johnson MedTech (Ethicon) Basic Information, Manufacturing Base and Competitors
Table 48. Johnson & Johnson MedTech (Ethicon) Major Business
Table 49. Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Product and Services
Table 50. Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Johnson & Johnson MedTech (Ethicon) Recent Developments/Updates
Table 52. Johnson & Johnson MedTech (Ethicon) Competitive Strengths & Weaknesses
Table 53. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 54. Medtronic plc Major Business
Table 55. Medtronic plc Lung Biopsy Systems Product and Services
Table 56. Medtronic plc Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Medtronic plc Recent Developments/Updates
Table 58. Medtronic plc Competitive Strengths & Weaknesses
Table 59. Olympus Corporation Basic Information, Manufacturing Base and Competitors
Table 60. Olympus Corporation Major Business
Table 61. Olympus Corporation Lung Biopsy Systems Product and Services
Table 62. Olympus Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Olympus Corporation Recent Developments/Updates
Table 64. Olympus Corporation Competitive Strengths & Weaknesses
Table 65. ERBE Elektromedizin GmbH Basic Information, Manufacturing Base and Competitors
Table 66. ERBE Elektromedizin GmbH Major Business
Table 67. ERBE Elektromedizin GmbH Lung Biopsy Systems Product and Services
Table 68. ERBE Elektromedizin GmbH Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. ERBE Elektromedizin GmbH Recent Developments/Updates
Table 70. ERBE Elektromedizin GmbH Competitive Strengths & Weaknesses
Table 71. Ambu A/S Basic Information, Manufacturing Base and Competitors
Table 72. Ambu A/S Major Business
Table 73. Ambu A/S Lung Biopsy Systems Product and Services
Table 74. Ambu A/S Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Ambu A/S Recent Developments/Updates
Table 76. Ambu A/S Competitive Strengths & Weaknesses
Table 77. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 78. Boston Scientific Corporation Major Business
Table 79. Boston Scientific Corporation Lung Biopsy Systems Product and Services
Table 80. Boston Scientific Corporation Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Boston Scientific Corporation Recent Developments/Updates
Table 82. Boston Scientific Corporation Competitive Strengths & Weaknesses
Table 83. Cook Medical LLC Basic Information, Manufacturing Base and Competitors
Table 84. Cook Medical LLC Major Business
Table 85. Cook Medical LLC Lung Biopsy Systems Product and Services
Table 86. Cook Medical LLC Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Cook Medical LLC Recent Developments/Updates
Table 88. Cook Medical LLC Competitive Strengths & Weaknesses
Table 89. KARL STORZ SE & Co. KG Basic Information, Manufacturing Base and Competitors
Table 90. KARL STORZ SE & Co. KG Major Business
Table 91. KARL STORZ SE & Co. KG Lung Biopsy Systems Product and Services
Table 92. KARL STORZ SE & Co. KG Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. KARL STORZ SE & Co. KG Recent Developments/Updates
Table 94. KARL STORZ SE & Co. KG Competitive Strengths & Weaknesses
Table 95. Technowood Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 96. Technowood Co., Ltd. Major Business
Table 97. Technowood Co., Ltd. Lung Biopsy Systems Product and Services
Table 98. Technowood Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Technowood Co., Ltd. Recent Developments/Updates
Table 100. Technowood Co., Ltd. Competitive Strengths & Weaknesses
Table 101. Sumitomo Bakelite Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 102. Sumitomo Bakelite Co., Ltd. Major Business
Table 103. Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Product and Services
Table 104. Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Sumitomo Bakelite Co., Ltd. Recent Developments/Updates
Table 106. Sumitomo Bakelite Co., Ltd. Competitive Strengths & Weaknesses
Table 107. HOYA Corporation (PENTAX Medical) Basic Information, Manufacturing Base and Competitors
Table 108. HOYA Corporation (PENTAX Medical) Major Business
Table 109. HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Product and Services
Table 110. HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. HOYA Corporation (PENTAX Medical) Recent Developments/Updates
Table 112. HOYA Corporation (PENTAX Medical) Competitive Strengths & Weaknesses
Table 113. FINEMEDIX CO., LTD. Basic Information, Manufacturing Base and Competitors
Table 114. FINEMEDIX CO., LTD. Major Business
Table 115. FINEMEDIX CO., LTD. Lung Biopsy Systems Product and Services
Table 116. FINEMEDIX CO., LTD. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. FINEMEDIX CO., LTD. Recent Developments/Updates
Table 118. FINEMEDIX CO., LTD. Competitive Strengths & Weaknesses
Table 119. Upex-Med Corp. Basic Information, Manufacturing Base and Competitors
Table 120. Upex-Med Corp. Major Business
Table 121. Upex-Med Corp. Lung Biopsy Systems Product and Services
Table 122. Upex-Med Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Upex-Med Corp. Recent Developments/Updates
Table 124. Upex-Med Corp. Competitive Strengths & Weaknesses
Table 125. Medcare Medical (Medcare Medical Co., Ltd.) Basic Information, Manufacturing Base and Competitors
Table 126. Medcare Medical (Medcare Medical Co., Ltd.) Major Business
Table 127. Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Product and Services
Table 128. Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Medcare Medical (Medcare Medical Co., Ltd.) Recent Developments/Updates
Table 130. Medcare Medical (Medcare Medical Co., Ltd.) Competitive Strengths & Weaknesses
Table 131. Argon Medical Devices, Inc. Basic Information, Manufacturing Base and Competitors
Table 132. Argon Medical Devices, Inc. Major Business
Table 133. Argon Medical Devices, Inc. Lung Biopsy Systems Product and Services
Table 134. Argon Medical Devices, Inc. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Argon Medical Devices, Inc. Recent Developments/Updates
Table 136. Argon Medical Devices, Inc. Competitive Strengths & Weaknesses
Table 137. Becton, Dickinson and Company (BD) Basic Information, Manufacturing Base and Competitors
Table 138. Becton, Dickinson and Company (BD) Major Business
Table 139. Becton, Dickinson and Company (BD) Lung Biopsy Systems Product and Services
Table 140. Becton, Dickinson and Company (BD) Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Becton, Dickinson and Company (BD) Recent Developments/Updates
Table 142. Becton, Dickinson and Company (BD) Competitive Strengths & Weaknesses
Table 143. Hunan Vathin Medical Instrument Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 144. Hunan Vathin Medical Instrument Co., Ltd. Major Business
Table 145. Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Product and Services
Table 146. Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Hunan Vathin Medical Instrument Co., Ltd. Recent Developments/Updates
Table 148. Hunan Vathin Medical Instrument Co., Ltd. Competitive Strengths & Weaknesses
Table 149. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 150. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Major Business
Table 151. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Product and Services
Table 152. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Recent Developments/Updates
Table 154. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Competitive Strengths & Weaknesses
Table 155. SonoScape Medical Corp. Basic Information, Manufacturing Base and Competitors
Table 156. SonoScape Medical Corp. Major Business
Table 157. SonoScape Medical Corp. Lung Biopsy Systems Product and Services
Table 158. SonoScape Medical Corp. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. SonoScape Medical Corp. Recent Developments/Updates
Table 160. SonoScape Medical Corp. Competitive Strengths & Weaknesses
Table 161. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 162. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Major Business
Table 163. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Product and Services
Table 164. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments/Updates
Table 166. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitive Strengths & Weaknesses
Table 167. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 168. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Major Business
Table 169. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Product and Services
Table 170. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Recent Developments/Updates
Table 172. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 173. Zhuji Peng Tian Medical Instrument Co.,Ltd Basic Information, Manufacturing Base and Competitors
Table 174. Zhuji Peng Tian Medical Instrument Co.,Ltd Major Business
Table 175. Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Product and Services
Table 176. Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Zhuji Peng Tian Medical Instrument Co.,Ltd Recent Developments/Updates
Table 178. Zhuji Peng Tian Medical Instrument Co.,Ltd Competitive Strengths & Weaknesses
Table 179. Global Key Players of Lung Biopsy Systems Upstream (Raw Materials)
Table 180. Global Lung Biopsy Systems Typical Customers
LIST OF FIGURES
Figure 1. Lung Biopsy Systems Picture
Figure 2. World Lung Biopsy Systems Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Lung Biopsy Systems Total Revenue (2021-2032) & (USD Million)
Figure 4. World Lung Biopsy Systems Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Lung Biopsy Systems Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 13. Lung Biopsy Systems Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 16. World Lung Biopsy Systems Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 18. China Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 23. India Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Lung Biopsy Systems by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Lung Biopsy Systems Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Lung Biopsy Systems Markets in 2025
Figure 27. United States VS China: Lung Biopsy Systems Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Lung Biopsy Systems Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Lung Biopsy Systems Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Lung Biopsy Systems Market Size Market Share by Type in 2025
Figure 31. Needle Biopsy
Figure 32. Thoracoscopic Biopsy
Figure 33. Transbronchial Biopsy
Figure 34. World Lung Biopsy Systems Market Size Market Share by Type (2021-2032)
Figure 35. World Lung Biopsy Systems Market Size by Access Route, (USD Million), 2021 & 2025 & 2032
Figure 36. World Lung Biopsy Systems Market Size Market Share by Access Route in 2025
Figure 37. Bronchoscopic
Figure 38. Percutaneous
Figure 39. World Lung Biopsy Systems Market Size Market Share by Access Route (2021-2032)
Figure 40. World Lung Biopsy Systems Market Size by Navigation Modality, (USD Million), 2021 & 2025 & 2032
Figure 41. World Lung Biopsy Systems Market Size Market Share by Navigation Modality in 2025
Figure 42. No Navigation
Figure 43. Electromagnetic Navigation
Figure 44. Robotic Navigation
Figure 45. Shape Sensing
Figure 46. World Lung Biopsy Systems Market Size Market Share by Navigation Modality (2021-2032)
Figure 47. World Lung Biopsy Systems Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Lung Biopsy Systems Market Size Market Share by Application in 2025
Figure 49. Hospitals
Figure 50. Cancer Research Centers
Figure 51. Specialty Clinics
Figure 52. Others
Figure 53. World Lung Biopsy Systems Market Size Market Share by Application (2021-2032)
Figure 54. Lung Biopsy Systems Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Lung Biopsy Systems Picture
Figure 2. World Lung Biopsy Systems Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Lung Biopsy Systems Total Revenue (2021-2032) & (USD Million)
Figure 4. World Lung Biopsy Systems Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Lung Biopsy Systems Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Lung Biopsy Systems Revenue (2021-2032) & (USD Million)
Figure 13. Lung Biopsy Systems Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 16. World Lung Biopsy Systems Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 18. China Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 23. India Lung Biopsy Systems Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Lung Biopsy Systems by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Lung Biopsy Systems Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Lung Biopsy Systems Markets in 2025
Figure 27. United States VS China: Lung Biopsy Systems Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Lung Biopsy Systems Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Lung Biopsy Systems Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Lung Biopsy Systems Market Size Market Share by Type in 2025
Figure 31. Needle Biopsy
Figure 32. Thoracoscopic Biopsy
Figure 33. Transbronchial Biopsy
Figure 34. World Lung Biopsy Systems Market Size Market Share by Type (2021-2032)
Figure 35. World Lung Biopsy Systems Market Size by Access Route, (USD Million), 2021 & 2025 & 2032
Figure 36. World Lung Biopsy Systems Market Size Market Share by Access Route in 2025
Figure 37. Bronchoscopic
Figure 38. Percutaneous
Figure 39. World Lung Biopsy Systems Market Size Market Share by Access Route (2021-2032)
Figure 40. World Lung Biopsy Systems Market Size by Navigation Modality, (USD Million), 2021 & 2025 & 2032
Figure 41. World Lung Biopsy Systems Market Size Market Share by Navigation Modality in 2025
Figure 42. No Navigation
Figure 43. Electromagnetic Navigation
Figure 44. Robotic Navigation
Figure 45. Shape Sensing
Figure 46. World Lung Biopsy Systems Market Size Market Share by Navigation Modality (2021-2032)
Figure 47. World Lung Biopsy Systems Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Lung Biopsy Systems Market Size Market Share by Application in 2025
Figure 49. Hospitals
Figure 50. Cancer Research Centers
Figure 51. Specialty Clinics
Figure 52. Others
Figure 53. World Lung Biopsy Systems Market Size Market Share by Application (2021-2032)
Figure 54. Lung Biopsy Systems Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
